Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3073)
All Articles published online
|
Oct 21, 2010 (publication date) through Jan 6, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Reni M. Neoadjuvant treatment for resectable pancreatic cancer: Time for phase III testing? World J Gastroenterol 2010; 16(39): 4883-4887 [PMID: 20954273 DOI: 10.3748/wjg.v16.i39.4883] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v16/i39/4883.htm |
| Number | Citing Articles |
| 1 |
Michele Reni, Gianpaolo Balzano, Giuseppe Aprile, Stefano Cereda, Paolo Passoni, Alessandro Zerbi, Maria Chiara Tronconi, Carlo Milandri, Piercarlo Saletti, Alessia Rognone, Clara Fugazza, Alessandro Magli, Nadia Di Muzio, Valerio Di Carlo, Eugenio Villa. Adjuvant PEFG (Cisplatin, Epirubicin, 5-Fluorouracil, Gemcitabine) or Gemcitabine Followed by Chemoradiation in Pancreatic Cancer: A Randomized Phase II Trial. Annals of Surgical Oncology 2012; 19(7): 2256 doi: 10.1245/s10434-011-2205-2
|
| 2 |
Kenjiro Kimura, Ryosuke Amano, Bunzo Nakata, Sadaaki Yamazoe, Keiichiro Hirata, Akihiro Murata, Kotaro Miura, Kohei Nishio, Toshiki Hirakawa, Masaichi Ohira, Kosei Hirakawa. Clinical and pathological features of five-year survivors after pancreatectomy for pancreatic adenocarcinoma. World Journal of Surgical Oncology 2014; 12(1): 360 doi: 10.1186/1477-7819-12-360
|
| 3 |
Fuyuhiko Motoi, Kazuyuki Ishida, Fumiyoshi Fujishima, Shigeru Ottomo, Masaya Oikawa, Takaho Okada, Hiromune Shimamura, Shinichi Takemura, Fuminori Ono, Masanori Akada, Kei Nakagawa, Yu Katayose, Shinichi Egawa, Michiaki Unno. Neoadjuvant Chemotherapy with Gemcitabine and S-1 for Resectable and Borderline Pancreatic Ductal Adenocarcinoma: Results from a Prospective Multi-institutional Phase 2 Trial. Annals of Surgical Oncology 2013; 20(12): 3794 doi: 10.1245/s10434-013-3129-9
|
| 4 |
Mukesh Verma. Pancreatic Cancer Biomarkers and Their Implication in Cancer Diagnosis and Epidemiology. Cancers 2010; 2(4): 1830 doi: 10.3390/cancers2041830
|
| 5 |
Asma Sultana, Trevor Cox, Paula Ghaneh, John P. Neoptolemos. Early Gastrointestinal Cancers. Recent Results in Cancer Research 2012; 196: 65 doi: 10.1007/978-3-642-31629-6_5
|
| 6 |
Jin-Zhi Xu, Wen-Quan Wang, Shi-Rong Zhang, Hua-Xiang Xu, Chun-Tao Wu, Zi-Hao Qi, He-Li Gao, Shuo Li, Quan-Xing Ni, Xian-Jun Yu, Liang Liu. Neoadjuvant Therapy is Essential for Resectable Pancreatic Cancer. Current Medicinal Chemistry 2020; 26(40): 7196 doi: 10.2174/0929867325666180413101722
|
| 7 |
M. Mura Assifi, Xuyang Lu, Guido Eibl, Howard A. Reber, Gang Li, O. Joe Hines. Neoadjuvant therapy in pancreatic adenocarcinoma: A meta-analysis of phase II trials. Surgery 2011; 150(3): 466 doi: 10.1016/j.surg.2011.07.006
|
| 8 |
Annika Eurola, Ari Ristimäki, Harri Mustonen, Anna-Maria Nurmi, Jaana Hagström, Pauliina Kallio, Kari Alitalo, Caj Haglund, Hanna Seppänen. β-catenin plus PROX1 immunostaining stratifies disease progression and patient survival in neoadjuvant-treated pancreatic cancer. Tumor Biology 2022; 44(1): 69 doi: 10.3233/TUB-211581
|
| 9 |
Xing Chen, Geng Liu, Kaiqiang Wang, Guodong Chen, Jinjin Sun. Neoadjuvant radiation followed by resection versus upfront resection for locally advanced pancreatic cancer patients: a propensity score matched analysis. Oncotarget 2017; 8(29): 47831 doi: 10.18632/oncotarget.18091
|
| 10 |
Ali Zakaria, Bayan Al-Share, Jason B. Klapman, Aamir Dam. The Role of Endoscopic Ultrasonography in the Diagnosis and Staging of Pancreatic Cancer. Cancers 2022; 14(6): 1373 doi: 10.3390/cancers14061373
|
| 11 |
Lucia Lombardi, Michele Troiano, Nicola Silvestris, Luciano Nanni, Tiziana Pia Latiano, Gabriele Di Maggio, Saverio Cinieri, Pierluigi Di Sebastiano, Giuseppe Colucci, Evaristo Maiello. Combined modality treatments in pancreatic cancer. Expert Opinion on Therapeutic Targets 2012; 16(sup2): S71 doi: 10.1517/14728222.2012.662959
|
| 12 |
Fuyuhiko Motoi, Michiaki Unno, Hidenori Takahashi, Takaho Okada, Keita Wada, Masayuki Sho, Hiroaki Nagano, Ippei Matsumoto, Sohei Satoi, Yoshiaki Murakami, Masashi Kishiwada, Goro Honda, Hisafumi Kinoshita, Hideo Baba, Shoichi Hishinuma, Minoru Kitago, Hidehiro Tajima, Hiroyuki Shinchi, Hiroshi Takamori, Tomoo Kosuge, Hiroki Yamaue, Tadahiro Takada. Influence of preoperative anti‐cancer therapy on resectability and perioperative outcomes in patients with pancreatic cancer: Project study by the Japanese Society of Hepato‐Biliary‐Pancreatic Surgery. Journal of Hepato-Biliary-Pancreatic Sciences 2014; 21(2): 148 doi: 10.1002/jhbp.15
|